Edition:
United States

Genomic Health Inc (GHDX.O)

GHDX.O on Nasdaq

32.78USD
25 Apr 2017
Change (% chg)

$0.00 (+0.00%)
Prev Close
$32.78
Open
$31.80
Day's High
$32.83
Day's Low
$31.80
Volume
98,710
Avg. Vol
124,329
52-wk High
$33.96
52-wk Low
$23.57

GHDX.O

Chart for GHDX.O

About

Genomic Health, Inc. is a healthcare company that provides genomic-based diagnostic tests to personalize cancer treatment. The Company develops and commercializes genomic-based clinical laboratory services. The Company's Oncotype IQ Genomic Intelligence Platform is consisted of its flagship line of Oncotype DX gene expression... (more)

Overall

Beta: 0.43
Market Cap(Mil.): $1,116.71
Shares Outstanding(Mil.): 34.07
Dividend: --
Yield (%): --

Financials

  GHDX.O Industry Sector
P/E (TTM): -- 58.01 30.10
EPS (TTM): -0.42 -- --
ROI: -9.22 0.27 13.21
ROE: -9.42 6.15 14.37

BRIEF-Genomic Health Q4 EPS $0.04

* Genomic health announces 2016 fourth quarter and year-end financial results, provides 2017 financial outlook

Feb 14 2017

BRIEF-Genomic Health Q3 loss per share $0.08

* Genomic Health reports third consecutive quarter of double-digit revenue growth in announcement of third quarter 2016 financial results

Nov 01 2016

BRIEF-Genomic Health reports positive topline clinical validation study results

* Genomic Health announces positive topline clinical validation study results demonstrating Oncotype DX prostate cancer test predicts risk of metastasis and mortality Source text for Eikon: Further company coverage:

Nov 01 2016

More From Around the Web

Earnings vs. Estimates